Amicus Therapeutics
Why Robinhood?
You can watch FOLD and buy or sell other stocks, ETFs, and their options commission-free!About FOLD
Amicus Therapeutics, Inc. is a biotechnology company, which engages in discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio.
FOLD Key Statistics
Stock Snapshot
Amicus Therapeutics(FOLD) stock is priced at $14.49, giving the company a market capitalization of 4.55B. It carries a P/E multiple of -163.54.
Amicus Therapeutics(FOLD) stock opened on 2026-04-28 at —. The price climbed to — and dipped to —.
The Amicus Therapeutics(FOLD)'s current trading volume is 0, compared to an average daily volume of 2.89M.
In the last year, Amicus Therapeutics(FOLD) shares hit a 52-week high of $14.50 and a 52-week low of $5.51.
In the last year, Amicus Therapeutics(FOLD) shares hit a 52-week high of $14.50 and a 52-week low of $5.51.
FOLD News
Advertisement Why Amicus Therapeutics is on investors’ radar today Amicus Therapeutics (FOLD) has caught investor attention after recent performance data show...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.